Inc. Aventis files SEC Form 4 disclosures for INTROGEN THERAPEUTICS INC. They have made 8 open-market trades across 1 company since 2006, most recently 2006-09-06.
CIK 0001356774
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INGN | 3,744,441 | $23.4M |
Shares reported on the most recent Form 4, priced at the 2006-09-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INGN | SELL | 2006-09-01 | 2006-09-06 | $3.99 | $214K | -9.6% | +1.0% | +1.0% |
| INGN | SELL | 2006-08-31 | 2006-09-05 | $3.96 | $133K | -9.6% | +1.0% | +1.0% |
| INGN | SELL | 2006-08-16 | 2006-08-18 | $3.85 | $159K | -9.6% | +1.0% | +1.0% |
| INGN | SELL | 2006-08-15 | 2006-08-16 | $3.90 | $83K | -9.6% | +1.0% | +1.0% |
| INGN | SELL | 2006-08-11 | 2006-08-14 | $3.90 | $253K | -9.6% | +1.0% | +1.0% |
| INGN | SELL | 2006-04-04 | 2006-04-06 | $5.42 | $357K | -9.6% | +1.0% | +1.0% |
| INGN | SELL | 2006-03-28 | 2006-03-30 | $5.31 | $51K | -9.6% | +1.0% | +1.0% |
| INGN | SELL | 2006-03-20 | 2006-03-22 | $5.31 | $67K | -9.6% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.